1-2 of 2
Ian F. Thomas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A randomized comparison of daunorubicin 90 mg/m 2 vs 60 mg/m 2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

CME Clinical Trials & Observations
Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Jonathan Kell, Jamie Cavenagh, Lars Kjeldsen, Mary-Frances McMullin, Paul Cahalin, Mike Dennis, Lone Friis, Ian F. Thomas, Don Milligan, Richard E. Clark
Journal: Blood
Blood (2015) 125 (25): 3878–3885.
https://doi.org/10.1182/blood-2015-01-623447
Published: 2015
Includes: Supplemental data
Journal Articles

Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia

Clinical Trials & Observations
Mike Dennis, Nigel Russell, Robert K. Hills, Claire Hemmaway, Nicki Panoskaltsis, Mary-Frances McMullin, Lars Kjeldsen, Helen Dignum, Ian F. Thomas, Richard E. Clark, Don Milligan, Alan K. Burnett
Journal: Blood
Blood (2015) 125 (19): 2923–2932.
https://doi.org/10.1182/blood-2014-10-608117
Published: 2015
Includes: Supplemental data